Navigation Links
Neogen Acquires International Diagnostic Systems
Date:5/4/2009

LANSING, Mich., May 4 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) has acquired International Diagnostic Systems Corp (IDS), a leading developer, manufacturer and marketer of test kits to detect drug residues in food and animal feed, and drugs in forensic and animal samples.

Based in St. Joseph, Mich., IDS has been in business for more than 20 years, and offers approximately 40 products. In addition to significant sales in the United States, IDS has distribution in France, Italy, Spain, Germany, and China. A key recent focus of the company has been the food safety market for testing animal feed, meat products, and seafood. IDS recorded revenues of approximately $2 million in its most recently completed fiscal year. Terms of the acquisition were not disclosed.

A part of IDS's operations will be relocated to and integrated with Neogen's Lexington, Ky., facilities. The company's research and development operations, and key IDS employees, will remain in IDS's Michigan facilities.

"We are pleased to have several valuable employees, with many years of experience at IDS, join Neogen," said Lon Bohannon, Neogen's president. "International Diagnostic's products are complementary and a nice fit with our existing forensic and drug detection product lines. The IDS purchase also provides Neogen with key collaborative relationships with influential industry partners, and increased access to important international markets, including China."

"We've had a long-standing respect for Neogen as both a competitor and a leader in supplying solutions for food and animal safety," said Deborah Morris, IDS's president. "We are pleased to be joining Neogen and helping to expand its markets."

IDS has been providing rapid immunoassay products for use in agriculture and veterinary markets since 1986. In the late 1980s, IDS began selling drug monitoring products to the horse and dog racing industry. In recent years, IDS expanded into the human forensics drug testing market.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

Certain portions of this news release that do not relate to historical financial information constitute forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties. Actual future results and trends may differ materially from historical results or those expected depending on a variety of factors listed in Management's Discussion and Analysis of Financial Condition and Results of Operations in the Company's most recently filed Form 10-K.


'/>"/>
SOURCE Neogen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NeoGenomics, Inc. Reports First Quarter 2009 Financial Results
2. NeoGenomics Schedules its Q1 2009 Earnings Release for April 23, 2009
3. NeoGenomics Appoints Douglas M. VanOort as Executive Chairman and Interim Chief Executive Officer
4. Neogen Reactivates Share Repurchase Program
5. NeoGenomics to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference
6. Webcast Alert: Neogen Corporation To Announce 2nd Quarter Results
7. NeoGenomics Schedules Its Q3 2008 Earnings Release for November 6, 2008
8. NeoGenomics to Present at the Noble Financial Equity Conference
9. NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008
10. NeoGenomics Announces Results for the 3rd Quarter 2007
11. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... , ... 21 Middle East and South Asia Leaders Selected as Eisenhower Fellows ... and civil society in 11 countries across the Middle East and South Asia to ... exchange of knowledge and ideas with the leading minds in their fields. , ...
(Date:6/23/2017)... ... , ... PureLife Dental is pleased to announce that California Dental Association (CDA) ... of the amalgam separator endorsement, all CDA members may purchase an ECO II amalgam ... value. This partnership between PureLife and CDA is especially timely as it coincides with ...
(Date:6/23/2017)... , ... June 23, 2017 , ... American Farmer, will ... series, which is slated to air fourth quarter 2017. American Farmer airs Tuesdays at ... Hansen, a Danish pharmacist, founded Chr. Hansen in Denmark in 1874 after a groundbreaking ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... and related services to families and business owners in and around Lackawanna County, ... benefit senior citizens in the area. , Meals on Wheels of NEPA provides ...
(Date:6/23/2017)... ... June 23, 2017 , ... All-Star Insurance, a family managed agency that ... eastern Texas, is announcing the launch of a new charity drive to benefit women ... the United States reveal that an estimated 252, 710 new cases of invasive or ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 2017  Less than a month ago, amateur hackers ... companies, including hospital networks, in over 150 countries. ... the largest online extortion attempts ever recorded. With the ... is imperative that providers understand where the risks lie, ... — and many other very real cyber threats.  ...
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
Breaking Medicine Technology: